Efficacy and safety of pharmacological treatments in inclusion body myositis: a systematic review
Objective To identify the best evidence on the efficacy of treatment interventions for inclusion body myositis (IBM) and to describe their safety.Methods Systematic review of randomised controlled trials (RCTs) of pharmacological treatments of adults with IBM, conducted according to the Cochrane Han...
Saved in:
Main Authors: | Pedro M Machado, Eduardo José Ferreira Santos, Nicholas Yapp, Pedro Sousa, Bayram Farisogullari, Hermaleigh Townsley |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2025-01-01
|
Series: | RMD Open |
Online Access: | https://rmdopen.bmj.com/content/11/1/e005176.full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Sporadic inclusion body myositis in the rheumatology clinic
by: Fernando Henrique Carlos de Souza, et al.
Published: (2020-01-01) -
Multi-omics analysis in inclusion body myositis identifies mir-16 responsible for HLA overexpression
by: Daphne Wijnbergen, et al.
Published: (2025-01-01) -
Injection of Botulinum Toxin a to Upper Esophageal Sphincter for Oropharyngeal Dysphagia in Two Patients with Inclusion Body Myositis
by: Louis WC Liu, et al.
Published: (2004-01-01) -
Retrospective analysis of US veterans with inclusion body myositis: initial findings from the Veterans Affairs Corporate Data Warehouse
by: Vladimir M. Liarski
Published: (2025-01-01) -
Efficacy and safety of non-pharmacological interventions for neonatal pain: an overview of systematic reviews
by: Xufei Luo, et al.
Published: (2022-09-01)